Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference 2024-01-11 11:53
Robooter Showcases Innovative Power Wheelchair X40 at CES 2024 2024-01-11 01:00
New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA 2024-01-10 16:50
LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024 2024-01-10 08:55
Toratani Co., Ltd. Unveils Groundbreaking "Virtuous Circulation Pillow and Mattress" with Patented Technology for Enhanced Deep Breathing Experience 2024-01-09 21:00
Baopu Development Joins IWBI's WELL for Residential Program 2024-01-09 16:32
Enhancing Leadership in Gynecology, Asieris Pharmaceuticals Appoints Sophia Cao to Lead the Newly-Established Women's Health Business Unit, Accelerating Strategic Expansion 2024-01-09 12:25
Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021） 2024-01-09 08:30
WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site 2024-01-08 22:00
Akeso to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Share Its Corporate & Innovative Clinical Development Roadmap 2024-01-08 21:38
Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC) 2024-01-08 19:35
So-Young Announces Update on Repurchase and Cancellation of Shares 2024-01-08 19:00
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts 2024-01-08 17:52
Caliway Announces FDA Acceptance of CBL-514 IND Application for Placebo-Controlled Phase 2 Study to treat Dercum's Disease 2024-01-08 13:25
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis 2024-01-08 07:00
Nuvilab Innovates Inpatient Nutrition with Food AI at Alexandra Hospital Singapore 2024-01-05 22:46
Supplemental New Drug Application for Akeso's Cadonilimab (PD-1/CTLA-4) Accepted by NMPA for First-line Treatment of Gastric Cancer 2024-01-05 21:00
Grant of Restricted Share Units to Mr. Xing Jin 2024-01-05 19:00
SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease 2024-01-05 16:00
OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients 2024-01-04 21:11
1 42 43 44 45 46 788